Acquired combined immunodeficiency associated with protein losing enteropathy complicating Fontan operation

Heart

Volumn 89, Issue 10, 2003, Pages 1130-1131

  Chakrabarti, S ^a   Keeton, B R ^a   Salmon, A P ^a   Vettukattil, Joseph J ^a  

^a Wessex Cardiac Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DIURETIC AGENT; HEPARIN; PREDNISOLONE; STEROID;

ANAMNESIS; BLOOD EXAMINATION; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; FONTAN PROCEDURE; GLUCOSE INTOLERANCE; HUMAN; HYPOGAMMAGLOBULINEMIA; HYPOPLASTIC LEFT HEART SYNDROME; IMMUNE DEFICIENCY; LABORATORY TEST; LUNG ATRESIA; LYMPHOCYTOPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN LOSING GASTROENTEROPATHY; REVIEW; URINALYSIS;

EID: 0141567477     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.10.1130     Document Type: Review

References (15)

1. Feldt RH, Driscoll DJ, Offord KP, et al. Protein losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 1996;112:672-80.
2. Valberg LS, Corbett WEN, McCorriston JR. Excessive loss of plasma protein into the gastrointestinal tract associated with primary myocardial disease. Am J Med 1965;39:668-73.
3. Krueger SK, Burney DW, Ferlic RM. Protein-losing enteropathy complicating the Mustard procedure. Surgery 1977;81:305-6.
4. Feldt RH, Driscoll DJ, Offord KP, et al. Five- to fifteen-year follow-up after Fontan operation. Circulation 1992;85:469-96.
5. Mertens L, Donald JH, Sauer U, et al. Protein-losing enteropathy after the Fontan operation: an international multicenter study. J Thorac Cardiovasc Surg 1998;115:1063-73.
6. Powell AJ, Gauvreau K, Jenkins KJ, et al. Perioperative risk factors for development of protein-losing enteropathy following a Fontan procedure. Am J Cardiol 2001;88:1206-9.
7. Kelly AM, Feldt RH, Driscoll DJ, et al. Use of heparin in the treatment of protein-losing enteropathy after Fontan operation for complex congenital heart disease. Mayo Clinic Proc 1998;73:777-9.
8. Rychik J, Spray TL. Strategies to treat protein-losing enteropathy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2002;5:3-11.
9. Garty BZ. Enteropathy and IgG subclass deficiency. J Pediatrics 1996;128:722-23.
10. Koch A, Hofbeck M, Feistel H. Circumscribed intestinal protein loss with deficiency in CD4+ lymphocytes after the Fontan procedure. Eur J Pediatrics 1999;158:847-50.
11. Muller C, Wolf H, Gottlicher J, et al. Cellular immunodeficiency in protein-losing enteropathy. Predominant reduction of CD3+ and CD4+ lymphocytes. Dig Dis Sci 1991;36:116-22.
12. Doe WF. Immunodeficiency and the gastrointestinal tract. Clin Gastroenterol 1983;12:839-53.
13. Aggarwal V, Williams MD, Beath SV. Gastrointestinal problems in the immunosuppressed patient. Arch Dis Child 1998;78:5-8.
14. Cheung YF, Leung MP, Yuen KY. Legionella pneumonia and bacteraemia in association with protein-losing enteropathy after Fontan operation. J Infection 2001;42:206-7.
15. De Giocoso C, Maggiore G, Scotta MS. Administration of intravenous immunoglobulin in two children with hypogammaglobulinaemia due to protein losing enteropathy. Clin Exp Immunol 1985;60:447-8.